治疗性血交换在皮质类固醇耐药复发性多发性硬化症中:机制,有效性和整合到临床实践中
Mariano Marrodan1, Maria C Ysrraelit1, Jorge Correale1,2
1Departamento de Neurología, Fleni, Buenos Aires C1428AQK, Argentina.
Biomedicines
|October 29, 2025
概括
治疗性血交换 (TPE) 提供了对严重多发性硬化症 (MS) 复发不响应类固醇的重要治疗方法. 这种疗法消除了有害的免疫成分,改善了许多患者的神经功能.
科学领域:
- 神经免疫学 神经免疫学
- 临床神经学 临床神经学
- 亚热医学 医学 亚热
背景情况:
- 急性多发性硬化症 (MS) 复发可能对高剂量皮质类固醇耐药.
- 幽默性免疫机制,包括自身抗体和补体激活,驱动了一组MS攻击的子集.
- 治疗性血交换 (TPE) 针对这些循环免疫因子.
研究的目的:
- 审查TPE在皮质类固醇耐药性MS中的机制性见解,临床疗效和实施策略.
- 整合来自临床试验和观察研究的证据.
- 讨论TPE在MS管理中的挑战和未来方向.
主要方法:
- 随机对照试验和观察队列的审查.
- 对机理学数据的分析,这些数据涉及MS病变发生过程中的幽默免疫.
- 对TPE的临床疗效和安全数据的综合.
主要成果:
- 在40-60%的耐药性MS复发患者中,TPE表现出中度到明显的功能改善.
- 当TPE在症状发作后14天内开始使用,以及在MRI病变活跃的情况下,观察到最佳益处.
- 反应的预测因素包括年龄较小,疾病持续时间较短,严重的神经综合征和特定的CSFB细胞标记.
结论:
- 对于某些重复性多发性硬化症患者来说,TPE是一种有价值的升级疗法,重复性硬化症患者对皮质类固醇无反应.
- 需要对协议的标准化,生物标志物验证和简化临床途径来增强TPE的采用.
- 进一步的研究应侧重于比较试验,生物标志物引导的选择和健康经济评估.
相关概念视频
01:30Electroconvulsive Therapy
849
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
849
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
173
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
173